Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1842 | 5623 | 47.6 | 93% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
251 | 42118 | EXPERIMENTAL HEMATOLOGY//THROMBOPOIETIN//JOURNAL OF INTERFERON RESEARCH |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1224 | 2680 | STAT3//STAT5//STAT |
8357 | 1192 | SOCS//SOCS1//SOCS3 |
10753 | 969 | INTERLEUKIN 7//IL 7//INTERLEUKIN 7 RECEPTOR |
15305 | 650 | TOFACITINIB//JAK3//CP 690 550 |
30818 | 132 | GRIM 19//OLFACTOMEDIN 4//GW112 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | STAT3 | Author keyword | 161 | 25% | 10% | 574 |
2 | INTERLEUKIN 7 | Author keyword | 99 | 50% | 3% | 143 |
3 | SOCS | Author keyword | 64 | 45% | 2% | 107 |
4 | IL 7 | Author keyword | 46 | 35% | 2% | 106 |
5 | SOCS3 | Author keyword | 43 | 38% | 2% | 90 |
6 | STAT | Author keyword | 43 | 24% | 3% | 159 |
7 | JAK | Author keyword | 43 | 34% | 2% | 104 |
8 | SOCS1 | Author keyword | 37 | 48% | 1% | 56 |
9 | INTERLEUKIN 7 RECEPTOR | Author keyword | 35 | 67% | 1% | 32 |
10 | STAT5 | Author keyword | 33 | 26% | 2% | 112 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | STAT3 | 161 | 25% | 10% | 574 | Search STAT3 | Search STAT3 |
2 | INTERLEUKIN 7 | 99 | 50% | 3% | 143 | Search INTERLEUKIN+7 | Search INTERLEUKIN+7 |
3 | SOCS | 64 | 45% | 2% | 107 | Search SOCS | Search SOCS |
4 | IL 7 | 46 | 35% | 2% | 106 | Search IL+7 | Search IL+7 |
5 | SOCS3 | 43 | 38% | 2% | 90 | Search SOCS3 | Search SOCS3 |
6 | STAT | 43 | 24% | 3% | 159 | Search STAT | Search STAT |
7 | JAK | 43 | 34% | 2% | 104 | Search JAK | Search JAK |
8 | SOCS1 | 37 | 48% | 1% | 56 | Search SOCS1 | Search SOCS1 |
9 | INTERLEUKIN 7 RECEPTOR | 35 | 67% | 1% | 32 | Search INTERLEUKIN+7+RECEPTOR | Search INTERLEUKIN+7+RECEPTOR |
10 | STAT5 | 33 | 26% | 2% | 112 | Search STAT5 | Search STAT5 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MICE LACKING SUPPRESSOR | 189 | 88% | 2% | 91 |
2 | IL 7 | 149 | 49% | 4% | 223 |
3 | CP 690 550 | 129 | 85% | 1% | 68 |
4 | JANUS TYROSINE KINASE | 128 | 88% | 1% | 60 |
5 | SIGNAL TRANSDUCER | 111 | 21% | 8% | 465 |
6 | CONSTITUTIVE ACTIVATION | 111 | 21% | 8% | 476 |
7 | MICE LACKING JAK3 | 106 | 56% | 2% | 127 |
8 | CYTOKINE SIGNALING 1 | 101 | 61% | 2% | 108 |
9 | BOX MOTIF | 99 | 88% | 1% | 46 |
10 | TRANSCRIPTION 3 | 86 | 44% | 3% | 148 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
STATs in cancer inflammation and immunity: a leading role for STAT3 | 2009 | 942 | 153 | 47% |
SOCS proteins, cytokine signalling and immune regulation | 2007 | 529 | 106 | 64% |
The stats of cancer - New molecular targets come of age | 2004 | 1083 | 117 | 57% |
The JAK-STAT Pathway at Twenty | 2012 | 194 | 97 | 46% |
STATs: Transcriptional control and biological impact | 2002 | 1435 | 151 | 58% |
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment | 2007 | 560 | 119 | 47% |
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors | 2014 | 32 | 279 | 48% |
JAK-STAT signaling: From interferons to cytokines | 2007 | 380 | 63 | 60% |
SOCS regulation of the JAK/STAT signalling pathway | 2008 | 192 | 132 | 86% |
The JAK-STAT signaling pathway: Input and output intergration | 2007 | 382 | 61 | 54% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL CELLULAR IMMUNOL | 15 | 24% | 1.0% | 55 |
2 | COOPERAT CELLULAR GROWTH TORS | 13 | 35% | 0.5% | 29 |
3 | MOL IMMUNOL INFLAMMAT BRANCH | 9 | 21% | 0.7% | 37 |
4 | UNITE IMMUNOGENET CELLULAIRE | 7 | 33% | 0.3% | 17 |
5 | BIOL PROTECT | 6 | 42% | 0.2% | 11 |
6 | SECT CYTOKINES IMMUN | 5 | 60% | 0.1% | 6 |
7 | CANC HAEMATOL | 5 | 19% | 0.4% | 23 |
8 | ABT ZELLULARE SIGNALVERARBEITUNG | 5 | 63% | 0.1% | 5 |
9 | SIGNAL NETWORK | 5 | 31% | 0.2% | 13 |
10 | EXPT BMT PROGRAM | 4 | 75% | 0.1% | 3 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000021642 | THROMBOPOIETIN//ONCOSTATIN M//LEUKEMIA INHIBITORY FACTOR |
2 | 0.0000017883 | JOURNAL OF INTERFERON RESEARCH//ISG15//JOURNAL OF INTERFERON AND CYTOKINE RESEARCH |
3 | 0.0000015070 | INTERLEUKIN 18//IL 18//IL 17 |
4 | 0.0000014854 | PIM 2//TRANSLATIONALLY CONTROLLED TUMOR PROTEIN//TCTP |
5 | 0.0000013336 | ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS |
6 | 0.0000011129 | PROLACTIN//PROLACTIN RECEPTOR//PHOSPHORYLATED PROLACTIN |
7 | 0.0000009165 | NOONAN SYNDROME//COSTELLO SYNDROME//THROMBOSPONDIN 1 |
8 | 0.0000009079 | FOXP3//CTLA 4//REGULATORY T CELLS |
9 | 0.0000008150 | TETRASPANIN//CD9//CD151 |
10 | 0.0000006955 | X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK |